FindTrial
Sign In

Assessment of Macular Microvascular Changes in Different Stages of Diabetic Retinopathy in diabetic patients Using OCTA and its reliability on disease progression.

Assessment of Macular vessel density in different stages of non proliferative diabetic retinopathy - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/12/098915
Enrollment
68
Registered
2025-12-11
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E113- Type 2 diabetes mellitus with ophthalmic complications

Interventions

Intervention1: Nil: Nil

Sponsors

Esic medical College and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of type 2 diabetes mellitus.

Exclusion criteria

Exclusion criteria: Patient with proliferative diabetic retinopathy. Presence of other retinal pathologies. History of intraocular surgery. Media opacity. Glaucoma. Intraocular inflammation.

Design outcomes

Primary

MeasureTime frame
Mean of Macular vessel densityTimepoint: 1 year—

Secondary

MeasureTime frame
Foveal avascular zone Timepoint: 1 year;Central macular thicknessTimepoint: 1 year—

Countries

India

Contacts

Public ContactDr Anju Rastogi

Esic medical College and hospital, faridabad

dranjurastogi@yahoo.co.in9818340924

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026